Kiora Pharmaceuticals Inc.
Organization details
- Legal name
- Kiora Pharmaceuticals Inc.
- Former names
- Eyegate Pharmaceuticals Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Encinitas
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KPRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001372514
- EIN
- 98-0443284
Board of directors
-
Aron Shapiro · DirectorSince 2023
-
Brian M. Strem · Director · President and CEOSince 2023
-
Carmine N. Stengone · DirectorSince 2023
-
David Hollander · DirectorSince 2023
-
Erin Parsons · DirectorSince 2023
-
Kenneth L. Gayron · DirectorSince 2023
-
Lisa Walters-Hoffert · DirectorSince 2024
-
Paul G. Chaney · DirectorSince 2023
-
Praveen Tyle · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.4%
-
98.6%
-
99.3%
Board connections
4 of this board's directors also sit on 4 other boards. 2 are in the same sector.
-
Contineum Therapeutics Inc. Same sectorvia Carmine N. Stengone
- via Lisa Walters-Hoffert
- via Kenneth L. Gayron
-
Skye Bioscience Inc. Same sectorvia Praveen Tyle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Brian M. Strem Director, Officer (President and CEO) | Shares withheld for tax | −1,869 | $2.66 | $4,972 |
| Jul 1, 2026 | Tosca Melissa Officer (CFO) | Shares withheld for tax | −911 | $2.66 | $2,423 |
| Apr 1, 2026 | Tosca Melissa Officer (CFO) | Shares withheld for tax | −929 | $1.95 | $1,812 |
| Apr 1, 2026 | Daniels Eric Joseph Officer (Chief Development Officer) | Shares withheld for tax | −929 | $1.95 | $1,812 |
| Apr 1, 2026 | Brian M. Strem Director, Officer (President and CEO) | Shares withheld for tax | −1,906 | $1.95 | $3,717 |
| Mar 6, 2026 | Daniels Eric Joseph Officer (Chief Development Officer) | Grant or award | +6,533 | — | — |
| Mar 6, 2026 | Brian M. Strem Director, Officer (President and CEO) | Grant or award | +16,733 | — | — |
| Mar 6, 2026 | Tosca Melissa Officer (CFO) | Grant or award | +6,533 | — | — |
| Mar 3, 2026 | Daniels Eric Joseph Officer (Chief Development Officer) | Shares withheld for tax | −238 | $2.02 | $481 |
| Mar 3, 2026 | Brian M. Strem Director, Officer (President and CEO) | Shares withheld for tax | −238 | $2.02 | $481 |
| Apr 1, 2025 | Tosca Melissa Officer (CFO) | Grant or award | +7,772 | — | — |
| Apr 1, 2025 | Daniels Eric Joseph Officer (Chief Development Officer) | Grant or award | +7,772 | — | — |
| Apr 1, 2025 | Brian M. Strem Director, Officer (President and CEO) | Grant or award | +15,941 | — | — |
| Sep 11, 2024 | Carmine N. Stengone Director | Open-market purchase | +1,250 | $3.68 | $4,600 |
| Sep 10, 2024 | Aron Shapiro Director | Open-market purchase | +3,000 | $3.60 | $10,800 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Kiora Pharmaceuticals Inc.
Who is the CEO of Kiora Pharmaceuticals Inc.?
Brian M. Strem is Kiora Pharmaceuticals Inc.'s President and CEO.
How many directors are on Kiora Pharmaceuticals Inc.'s board?
Kiora Pharmaceuticals Inc.'s board has 9 directors: Aron Shapiro, Brian M. Strem, Carmine N. Stengone, David Hollander, Erin Parsons, Kenneth L. Gayron, Lisa Walters-Hoffert, Paul G. Chaney and Praveen Tyle.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="kiora-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.